Observational studyThe Annals of pharmacotherapy2018
Critical Care Pharmacists and Medication Management in an ICU Recovery Center.
Observational study in The Annals of pharmacotherapy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
27 citing papers in PubMed, 1 synthesis or guideline pooled it, 76 citations in OpenAlex.
- Medication-related interventions to improve medication safety and patient outcomes on transition from adult intensive care settings: a systematic review and meta-analysis.BMJ quality & safety · 2022Pooled it
- Patient-psychologist telemedicine interactions in an intensive care unit recovery clinic: Qualitative secondary analysis.Intensive & critical care nursing · 2025Trial
- Multidisciplinary ICU Recovery Clinic Visits: A Qualitative Analysis of Patient-Provider Dialogues.Chest · 2023Trial
- Best possible medication history interview guide: a rapid scoping review.BMJ open quality · 2026Article
- Identifying and Resolving Drug-Related Problems in Geriatric Patients.Hospital pharmacy · 2026Review
- Post-Intensive Care Syndrome: Physical Impairments and Function.Critical care clinics · 2025Review
- Effect of Inpatient Pharmacist-Led Medication Reconciliations on Medication-Related Interventions in Intensive Care Unit Recovery Centers.Hospital pharmacy · 2024Article
- Post-intensive care syndrome follow-up system after hospital discharge: a narrative review.Journal of intensive care · 2024Review
- The roles and patterns of critical care pharmacists: a literature review and practical operation model in China.Frontiers in pharmacology · 2024Review
- Factors Influencing Influenza and COVID-19 Vaccine Decision-Making in the Post-ICU Period: A Secondary Analysis.CHEST critical care · 2023Article
- Comprehensive Acute Kidney Injury Survivor Care: Protocol for the Randomized Acute Kidney Injury in Care Transitions Pilot Trial.JMIR research protocols · 2023Article
- Clinical frailty and polypharmacy in older emergency critical care patients: a single-centre retrospective case series.European journal of hospital pharmacy : science and practice · 2023Article
- Factors Influencing Engagement with in-Person Intensive Care Unit Recovery Clinic Services.Journal of intensive care medicine · 2023Article
- Article
- Characteristics of Post-ICU and Post-COVID Recovery Clinics in 29 U.S. Health Systems.Critical care explorations · 2022Article
- Association between unmet medication needs after hospital discharge and readmission or death among acute respiratory failure survivors: the addressing post-intensive care syndrome (APICS-01) multicenter prospective cohort study.Critical care (London, England) · 2022Article
- Optimizing Critical Illness Recovery: Perspectives and Solutions From the Caregivers of ICU Survivors.Critical care explorations · 2021Article
- Article
- Are We "Closing the Loop" on Meeting the Therapeutic Needs of Critically Ill Patients?The Canadian journal of hospital pharmacy · 2021Article
- An Analysis of Psychoactive Medications Initiated in the ICU but Continued Beyond Discharge: A Pilot Study of Stewardship.Journal of pharmacy practice · 2020Observational
Corrections and comments
- Commented on by
- Commented on by
Authors and funding
6 authors at 2 institutions in 1 country.
Funding
Abstract
backgroundMany patients experience complications following critical illness; these are now widely referred to as post-intensive care syndrome (PICS). An interprofessional intensive care unit (ICU) recovery center (ICU-RC), also known as a PICS clinic, is one potential approach to promoting patient and family recovery following critical illness.
objectivesTo describe the role of an ICU-RC critical care pharmacist in identifying and treating medication-related problems among ICU survivors.
methodsA prospective, observational cohort study was conducted of all outpatient appointments of a tertiary care hospital's ICU-RC between July 2012 and December 2015. The pharmacist completed a full medication review, including medication reconciliation, interview, counseling, and resultant interventions, during the ICU-RC appointment.
resultsData from all completed ICU-RC visits were analyzed (n = 62). A full medication review was performed in 56 (90%) of these patients by the pharmacist. The median number of pharmacy interventions per patient was 4 (interquartile range = 2, 5). All 56 patients had at least 1 pharmacy intervention; 22 (39%) patients had medication(s) stopped at the clinic appointment, and 18 (32%) patients had new medication(s) started. The pharmacist identified 9 (16%) patients who had an adverse drug event (ADE); 18 (32%) patients had ADE preventive measures instituted. An influenza vaccination was administered to 13 (23%) patients despite an inpatient protocol to ensure influenza vaccination prior to discharge. A pneumococcal vaccination was administered to 2 (4%) patients.
conclusionsUse of a critical care pharmacist resulted in the identification and treatment of multiple medication-related problems in an ICU-RC as well as implementation of preventive measures.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.